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It was observed by Oettel (1) in 1936 that the peroral adminis-
tration of hydroquinone to black haired cats turned the hair
gray. Discontinuation of the drug resulted in repigmentation
of the hair. In an investigation of occupational leukoderma by
Oliver, Schwartz and Warren (2, 3), it was found that the mono-
benzyl ether of hydroquinone, contained as an antioxidant in the
rubber gloves of the workers, was responsible for the depigmenta-
tion. Their experiments as well as our own demonstrated that the
depigmentation was due to the action of monobenzyl hydro-
quinone on the system "dopa"-oxidase dihydroxyphenyl alanine
("dopa").
EXPERIMENTAL PART
In a number of human subjects, both white and colored, the
monobenzyl compound was applied in the form of a 50 per cent
ointment or as a 50 per cent ethereal suspension. In a few
instances the concentrated powder was used. Leukoderma was
produced after incubation periods varying from weeks to months.
Histologic examination of the areas of depigmentation revealed
a negative "dopa" reaction and an almost complete disappearance
of the melanin. The microscopic picture could not be dif-
ferentiated from a viteligo in many instances since the depig-
mentation was seen to occur without preceding inflammatory
reaction.
A number of guinea pigs were fed approximately 12 grams of
monobenzyl ether of hydroquinone over a period of 5 months.
This was well tolerated but no pigmentary changes were observed.
* From the Laboratories of The Mount Sinai Hospital, New York.
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Local application over a period of months, just as in the human
subjects, caused depigmentation. The disappearance of the
pigment was accompanied by a negative "dopa" reaction in the
affected areas. This observation only applied to the previously
pigmented epidermis whereas the hair bulbs were not affected.
This was probably due to a lack of penetration of the monobenzyl
compound to the melanoblasts in the hair matrix.
When blood smears are exposed to a 0.1 per cent "dopa"
solution according to the method of Bloch and Peck (4), a striking
effect of polyphenolase on "dopa" is observed which is manifested
by the formation of intense black granules in the leukocytes.
The blood smears are first fixed in formalin vapor before im-
mersion in the "dopa" solution. When such a fixed preparation
is exposed to ether or ethanol for 1 hour prior to immersion in
"dopa" solution, the oxidase reaction is markedly weakened or
in some instances even completely abolished. However, if the
formalin fixed blood smears are immersed in an ethereal solution
of monobenzyl ether of hydroquinone in concentrations of 1 to
5 per cent for a period of 1 hour the action of the oxidase on the
"dopa" solution is increased. Moreover, blood films in which the
oxidase action has apparently been abolished by previous exposure
to ether for a period of several hours can be brought back to full
activity by the monobenzyl compound and the enhanced effect
described above may then be seen. When monomethyl ether of
hydroquinone and dibenzylether were substituted for the mono-
benzyl compound the enhanced effect was not observed.
The action of hydroquinone monobenzyl ether and other so-
called anti-oxidants on oxidase systems in vitro was also studied.
Tryosinase was prepared from potatoes (5). This acts upon
"dopa", tyrosine and non-nitrogenous polyphenols. The oxida-
tion of tyrosine by this "potato tyrosinase" first leads to dihy-
droxyphenyl alanine; the latter reacts faster than tyrosine and
according to Raper and Wormall (6) the further reaction takes
place in three steps. The first step yields a red substance. The
second step, which may only be observed under special precautions
leads to a colorless phase from which melanin then forms as the
end product.
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When 15 to 0 mg. of potato preparation are added to 5 ml.
of a phosphate buffered solution of 0.5 to 1.0 mg. of tyrosine or
"dopa," the pink stage appears within a few minutes, persists for
two hours and then gradually changes to melanin. When 0.2
ml. of a 1 per cent solution of Agerite alba' or of monobenzyl
ether of hydroquinone in alcohol is added to the preceding
mixture, development of the pink color lags behind the control
and the pink shades of the control are usually reached a few
hours later. However, instead of continuing to the melanin
stage, the pink product accumulates without being further
converted to melanin even on prolonged standing over 12 hours.
There results a deep purple solution which continues to be trans-
parent in spite of the depth of the color. This is in marked
contrast to the reiatiiely opaque colloidal melanin suspensions
in the controls. In control experiments with 0.2 ml. of alcohol
without antioxidant, normal melanin formation took place.
When the monobenzyl ether of hydroquinone is incubated without
the potato enzyme, it does not form colored oxidation products
in spite of its monophenolic chars eter.
A crude oxidase was prepared from mealworms. The mono-
phenolase in this preparation is stronger and more stable than
potato enzyme and acts on the monobenzyl ether itself yielding
a red end product. When the monomethyl ether of hydroquinone
was used, instead of the monobenzyl ether or Agerite alba, similar
results were obtained but the color was not as pure.
The dibenzyl ether and a number of agerite antioxidants
designated "Agerite resin, AR powder, AR white" which consist
of aldol-a-naphthylamine, phenyl-$-naphthylamine, and sym.
cli-j3-naphthyl-p-phenylene diamine, have no effect on melanin
formation.
In a parallel series of experiments the potato enzyme was used
with and without Agerite aiba on the various diphenols. Catechol
in a solution of 1 mg. in 5 ml. pius potato enzyme in the same
concentrations as given above passed through a greenish-yellow
'"Agerite alba" is a trade name for an antioxidant which is reputed to be
monobeuzyl ether of hydroquinone containing less than 1 per cent unchanged
hydroquinone.
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stage but turned pink after 2 hours and on prolonged standing
melanin was formed. Test tubes which in addition contained
antioxidant stayed pink. The substrate alone and a solution
containing substrate and Agerite alba but no enzyme remained
practically colorless under the same conditions.
When resorcinol and hydroquinone plus the oxidase were used
with Agerite alba there was a definite increase in the oxidase
reaction. The resorcinol-containing solution first became yellow
and then passed into a stage showing strong green fluorescence.
Solutions containing hydroquinone first became pink and then
yellow. A solution without Agerite alba remained slightly pink.
When hydroquinone acetic acid2 (homogentisic acid) was used
in such a system, it turned pink, then yellow and on longer stand-
ing, a deep orange-yellow. Control solutions without Agerite
alba stayed slightly yellow.
It appears from these observations that mono ethers of hydro-
quinone inhibit the melanin formation by "dopa" oxidase in the
skin and by potato tyrosinase in vitro with "dopa" as well as with
tyrosine. They do not prevent the primary enzymatic reaction
leading to the pink orthoquinoid compound. As this compound
is in molecular solution it is too diffuse for microscopic observa-
tion; hence skin sections exposed to monobenzyl hydroquinone
appear less black than the controls.
SUMMARY AND CONCLUSIONS
1. The monobenzyl ether of hydroquinone specifically modifies
the action of "dopa" oxidase on the propigment in the melano-
blasts so that the reaction does not proceed to the melanin stage.
2. In contrast to the above the monobenzyl ether of hydro-
quinone enhances the effect of leukocyte polyphenolase on
dihydroxyphenyl alanine.
3. The action uf potato oxidase on tyrosine and dihydroxy-
phenyl alanine in vitro is interrupted by monobenzyl ether of
hydroquinone at the red stage.
2 Thiss betance was prepared for us by Prof. Mario Volterra from the urine of
an kaptorniric.
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